Oak Grants
These grants support large-scale research projects requiring more than $30,000 in funding, with an emphasis on scientific discovery to address canine health priorities.
Purpose of this Grant
The Oak Grants – named after Raleigh, NC, the “City of Oaks” and headquarters of CHF – provide funding of more than $30,000 to support larger, well-established studies and clinical trials addressing significant health priorities in dogs. These longer-term grants fund research aimed at developing innovative treatments, preventive measures, and diagnostic tools that make a substantial impact on scientific and medical advancements to benefit the health of dogs..
Who is Eligible
Eligible applicants include established investigators with
the expertise and resources to conduct large, high-impact research projects. Applications are subject to external peer review to ensure scientific quality and relevance.
Research Scientists
Investigators with a demonstrated research interest in canine health and the resources to conduct large-scale projects.
Veterinary Clinical Scientists
Clinicians in specialized disciplines such as cardiology, oncology, or surgery.
Research Institutions and Collaborations
Collaborative teams with multidisciplinary expertise and infrastructure to undertake complex, high-impact research.
FUNDING HIGHLIGHTS
Measuring the Impact of Oak Grants
640
Grants funded to date, advancing groundbreaking research in canine medicine.
$52M
Funding distributed to support transformative projects in canine health discovery.
15+
Countries have received grants, fostering global collaboration in canine health.
Taking The Next Step
Ready to apply? Visit our Request for Proposal page to stay updated on upcoming funding opportunities and get prepared to submit your application when the next cycle opens. Be sure to review the guidelines and eligibility requirements in advance.
Grants












Explore All Investigator Opportunities
Discover a range of funding options designed to support and advance your research in canine health.